117 related articles for article (PubMed ID: 16194701)
1. B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma.
Thompson RH; Webster WS; Cheville JC; Lohse CM; Dong H; Leibovich BC; Kuntz SM; Sengupta S; Kwon ED; Blute ML
Urology; 2005 Nov; 66(5 Suppl):10-4. PubMed ID: 16194701
[TBL] [Abstract][Full Text] [Related]
2. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Chen L; Zincke H; Blute ML; Leibovich BC; Kwon ED
Cancer; 2005 Nov; 104(10):2084-91. PubMed ID: 16208700
[TBL] [Abstract][Full Text] [Related]
3. Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.
Thompson RH; Dong H; Kwon ED
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):709s-715s. PubMed ID: 17255298
[TBL] [Abstract][Full Text] [Related]
4. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.
Thompson RH; Kuntz SM; Leibovich BC; Dong H; Lohse CM; Webster WS; Sengupta S; Frank I; Parker AS; Zincke H; Blute ML; Sebo TJ; Cheville JC; Kwon ED
Cancer Res; 2006 Apr; 66(7):3381-5. PubMed ID: 16585157
[TBL] [Abstract][Full Text] [Related]
5. Significance of B7-H1 overexpression in kidney cancer.
Thompson RH; Kwon ED
Clin Genitourin Cancer; 2006 Dec; 5(3):206-11. PubMed ID: 17239274
[TBL] [Abstract][Full Text] [Related]
6. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
[TBL] [Abstract][Full Text] [Related]
7. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.
Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Krejci KG; Lobo JR; Sengupta S; Chen L; Zincke H; Blute ML; Strome SE; Leibovich BC; Kwon ED
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17174-9. PubMed ID: 15569934
[TBL] [Abstract][Full Text] [Related]
8. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
Krambeck AE; Dong H; Thompson RH; Kuntz SM; Lohse CM; Leibovich BC; Blute ML; Sebo TJ; Cheville JC; Parker AS; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1749-56. PubMed ID: 17363528
[TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.
Siddiqui SA; Frigola X; Bonne-Annee S; Mercader M; Kuntz SM; Krambeck AE; Sengupta S; Dong H; Cheville JC; Lohse CM; Krco CJ; Webster WS; Leibovich BC; Blute ML; Knutson KL; Kwon ED
Clin Cancer Res; 2007 Apr; 13(7):2075-81. PubMed ID: 17404089
[TBL] [Abstract][Full Text] [Related]
10. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.
Parker AS; Kosari F; Lohse CM; Houston Thompson R; Kwon ED; Murphy L; Riehle DL; Blute ML; Leibovich BC; Vasmatzis G; Cheville JC
Cancer; 2006 Jul; 107(1):37-45. PubMed ID: 16736510
[TBL] [Abstract][Full Text] [Related]
11. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.
Sengupta S; Lohse CM; Leibovich BC; Frank I; Thompson RH; Webster WS; Zincke H; Blute ML; Cheville JC; Kwon ED
Cancer; 2005 Aug; 104(3):511-20. PubMed ID: 15973740
[TBL] [Abstract][Full Text] [Related]
12. Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival.
Webster WS; Lohse CM; Thompson RH; Dong H; Frigola X; Dicks DL; Sengupta S; Frank I; Leibovich BC; Blute ML; Cheville JC; Kwon ED
Cancer; 2006 Jul; 107(1):46-53. PubMed ID: 16708355
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers.
Nakanishi J; Wada Y; Matsumoto K; Azuma M; Kikuchi K; Ueda S
Cancer Immunol Immunother; 2007 Aug; 56(8):1173-82. PubMed ID: 17186290
[TBL] [Abstract][Full Text] [Related]
14. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.
Strome SE; Dong H; Tamura H; Voss SG; Flies DB; Tamada K; Salomao D; Cheville J; Hirano F; Lin W; Kasperbauer JL; Ballman KV; Chen L
Cancer Res; 2003 Oct; 63(19):6501-5. PubMed ID: 14559843
[TBL] [Abstract][Full Text] [Related]
15. Blockade of B7-H1 with sPD-1 improves immunity against murine hepatocarcinoma.
He L; Zhang G; He Y; Zhu H; Zhang H; Feng Z
Anticancer Res; 2005; 25(5):3309-13. PubMed ID: 16101143
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other.
Tollefson MK; Thompson RH; Sheinin Y; Lohse CM; Cheville JC; Leibovich BC; Kwon ED
Cancer; 2007 Aug; 110(4):783-90. PubMed ID: 17594714
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma.
Parker A; Lohse C; Cheville J; Leibovich B; Igel T; Blute M
Int J Urol; 2008 Apr; 15(4):304-8. PubMed ID: 18380816
[TBL] [Abstract][Full Text] [Related]
18. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
Curiel TJ; Wei S; Dong H; Alvarez X; Cheng P; Mottram P; Krzysiek R; Knutson KL; Daniel B; Zimmermann MC; David O; Burow M; Gordon A; Dhurandhar N; Myers L; Berggren R; Hemminki A; Alvarez RD; Emilie D; Curiel DT; Chen L; Zou W
Nat Med; 2003 May; 9(5):562-7. PubMed ID: 12704383
[TBL] [Abstract][Full Text] [Related]
19. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C
Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727
[TBL] [Abstract][Full Text] [Related]
20. External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma.
Ficarra V; Martignoni G; Lohse C; Novara G; Pea M; Cavalleri S; Artibani W
J Urol; 2006 Apr; 175(4):1235-9. PubMed ID: 16515968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
